Back on Track: Achieving Healthy Weight Loss

I hear this from so many of my patients: "Dr. Shelly, I haven't changed anything—not my diet, not my exercise—but I'm gaining weight and my body just doesn't respond the way it used to." If you're a woman in your 40s or 50s, you're probably nodding right now. In this episode, I'm walking you through exactly why menopause causes weight gain, why it has nothing to do with willpower, and what breakth...

A patient asked me this recently: "Dr. Shelley, I've heard that GLP-1 medications can cause muscle loss. Does that mean they can hurt my bones too?" It's an excellent question—and one we don't talk about nearly enough. In this episode, I'm walking you through what the research actually shows about GLP-1 medications and bone health, why weight loss itself poses a different risk to your skeleton, an...

Can retatrutide finally be the breakthrough obesity treatment we've been waiting for? The answer is yes—and the data is stunning. In this episode I'm walking you through the biggest obesity medicine discovery from the ADA's 86th Scientific Session: retatrutide, a triple hormone receptor agonist showing weight loss results that rival bariatric surgery. You'll learn what makes retatrutide different...

Can I restart my GLP-1? The answer is yes — but it requires a strategic plan.  In this episode I'm walking you through exactly what happens to your body when you restart a GLP-1, why the timing of your break matters more than you think, how to restart safely without landing yourself in misery, the biggest mistakes I see patients make, and how to get back on track without shame or guilt. Restarting...

You stopped your GLP-1 and now you're wondering can I just restart where I left off? Why am I so hungry again? Why are the side effects back? Did the medication stop working? These are questions I hear all the time in my practice. And the answer is not as simple as picking back up where you stopped. In this episode I am walking you through exactly what happens biologically when you stop a GLP-1, w...

A patient finally decides to prioritize their health. They wait weeks for an appointment. We talk, we plan, and they leave with hope. Then the pharmacy calls with a price tag over $1,000 a month and that hope disappears. If that's happened to you, I made this episode for you. Because what most patients don't know is that there are real, legitimate ways to make this work and I'm breaking all of the...

People keep asking the same question: what's actually the difference between all these weight loss medications?  Ozempic. Wegovy. Mounjaro. Zepbound. Foundayo. Wegovy pill. Some of these medications are injections, some are pills, some are FDA-approved for diabetes, others for weight loss, and some are actually the same medication with completely different brand names. So I'm breaking it all down...

Medicare has spent years telling obesity patients: your medication isn't covered. Starting July 1, 2026, that may finally start to change. In this episode, I will break down the new Medicare GLP-1 Bridge Demonstration Program — what it is, who qualifies, and which medications may be covered. This is not just a policy update. For thousands of patients who have paid hundreds of dollars out of pocket...

Your weight loss medication was denied. That moment of hope is gone. But this is not a 'you' problem. It's a system problem. In this episode, I break down why insurance denials for weight loss medications happen so frequently, and more importantly, what you can actually do about it. From formulary exclusions to step therapy requirements to the documentation timing that can reset your entire approv...

Weight loss plateaus on GLP-1 therapies such as Wegovy and Zepbound are increasingly understood as a function of biological adaptation rather than patient noncompliance. In this episode I will be discussing CagriSema, an investigational combination therapy expected to launch between late 2026 and early 2027. The treatment combines semaglutide and cagrilintide, targeting complementary mechanisms th...

If you're looking for weight loss options but don't want injections, things just changed in a big way. In this episode, I break down a new class of weight loss pills, including Foundayo (orforglipron), the newest GLP-1 option that was just approved. Unlike older treatments, this pill is designed to be simple. No fasting. No strict timing. You can take it with food or even coffee. We also look at h...

If Wegovy has helped you — but not enough — the answer may not be more willpower. It may be a higher dose. The FDA just approved a new 7.2mg version of Wegovy, and the clinical data is turning heads. In this episode, I break down everything you need to know about this new higher dose — what the research shows, who it's designed for, and what it actually means for your weight loss journey. Weight l...

You're doing everything right — watching what you eat, trying to stay active — and still the weight won't budge. If you have PCOS, this isn't a willpower problem. It's biology. And once you understand the cycle driving it, you can finally start to break it. PCOS creates a vicious cycle between high androgens, insulin resistance, and weight gain and each one feeds into the others. Your body isn't w...

If you've been struggling to lose weight and your thyroid came back abnormal, it's natural to connect the dots. But here's what I need you to know, the thyroid is not the whole story. In this episode, I break down exactly what your thyroid does and doesn't do when it comes to your weight. Yes, hypothyroidism affects your weight. But research shows it typically causes only 5 to 10 pounds of gain —...

If you've been eating barely anything and the scale still won't move, the problem might not be that you're eating too much. It might be that you're not eating enough.  And there's science behind why. "Why am I not losing weight?" It's the most frustrating question in my clinic. And the answer often surprises people.  Today, I'm answering it publicly — with research, not guesswork. In this episode,...

You've heard about the Wegovy shot. Now there's a pill — and the confusion is already spreading. Is it the same? Does it work as well? Can you take it with your other medications? In December, the FDA approved an oral form of semaglutide specifically for weight management and cardiovascular risk reduction. That's a game-changer — but only if you know how to use it correctly. Take it wrong and it w...

If you're on Wegovy, Zepbound, Ozempic, or Mounjaro — and worried about what happens when you stop — this episode is for you. The fear of gaining it all back is real. But weight regain is not inevitable. It's manageable. And I'm going to show you how. "What happens when you stop your GLP-1?" This is one of the most common questions I get in my clinic every single week. It's time I answered it publ...

Every single week in my clinic, I see smart, motivated people stuck in their weight loss journey not because they're doing something wrong, but because they believe something wrong. The myths surrounding weight loss are so deeply embedded in our culture that even some physicians still repeat them. And the cost? Shame, delayed treatment, and people giving up on themselves unnecessarily. I've spent...

You're doing all the right things—showing up to the gym, getting your steps in, strength training—but that scale? Still not moving. Sound familiar? In this episode, I'm breaking down exactly how to eat to support your workouts without sabotaging your weight loss goals—and without overthinking it. No sports nutrition degree required, I promise. I've seen too many patients work incredibly hard in th...

The 2025-2030 Dietary Guidelines for Americans just dropped, and they represent a major shift from rigid rules to personalized, sustainable nutrition. These aren't just recommendations—they shape what your doctor tells you, influence insurance policies, and determine what's served in schools and hospitals. In this episode, I break down the most important updates and translate them into simple, act...

In this important episode, I break down the newly FDA-approved Wegovy pill and what it means for obesity treatment. The first oral GLP-1 medication for obesity has arrived, offering a needle-free alternative to weekly injections. This development could transform access for patients who've avoided treatment due to injection hesitation, cost barriers, or preference for daily pill routines. Tune in t...

If you've fallen off your weight loss journey—whether from illness, the holidays, or life's unexpected turns—this episode will help you start moving forward again. I'm opening up about my own 2025 health crisis: developing blood clots in both lungs that stopped me in my tracks physically and emotionally. After significant weight gain and struggling to walk a mile that once took me 12 minutes, I'm...

As we close out 2025, I'm celebrating you—my listeners—by revisiting the year's most popular episodes. This isn't just a highlight reel; it's a roadmap to understanding why sustainable weight loss requires more than willpower. I'm sharing the most impactful insights from 2025 that tackle the hidden barriers blocking your progress: stress hormones storing belly fat, sleep deprivation hijacking your...

If you're over 60 and using GLP-1 medications like Wegovy or Zepbound, this episode could save your independence. In this episode, I reveal the hidden danger of rapid weight loss without muscle protection—and the simple strategies that keep you strong, steady, and mobile as the pounds come off. GLP-1 medications are transforming weight loss for older adults managing diabetes, high blood pressure,...

If you've been waiting for a GLP-1 weight loss medication that doesn't require injections, special timing, or refrigeration—this episode is for you. Learn about the groundbreaking oral pill that could hit the market as early as 2026. For years, effective obesity medications have meant needles. But Orforglipron could change everything. In this episode, I break down the science, clinical trial resul...